A Detailed Analysis of the Metered Dose Inhalers Market Based on Notably Increasing Prevalence of Respiratory Diseases Like COPD and Asthma, and Advancements in Inhalation Technology
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 186
Report ID: PMRREP33723
1. Executive Summary
1.1. Global Metered Dose Inhalers Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Type Lifecycle Analysis
2.4. Metered Dose Inhalers Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Metered Dose Inhalers Market Outlook: Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
3.3.3.1. Reliever Inhaler
3.3.3.2. Long-Acting Bronchodilators Inhaler
3.4. Market Attractiveness Analysis: Type
3.5. Global Metered Dose Inhalers Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Homecare
3.5.3.2. Hospitals
3.5.3.3. Clinics
3.6. Market Attractiveness Analysis: End User
4. Global Metered Dose Inhalers Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Type
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
5.5.1. Reliever Inhaler
5.5.2. Long-Acting Bronchodilators Inhaler
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Homecare
5.6.2. Hospitals
5.6.3. Clinics
5.7. Market Attractiveness Analysis
6. Europe Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
6.5.1. Reliever Inhaler
6.5.2. Long-Acting Bronchodilators Inhaler
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Homecare
6.6.2. Hospitals
6.6.3. Clinics
6.7. Market Attractiveness Analysis
7. East Asia Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Type
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
7.5.1. Reliever Inhaler
7.5.2. Long-Acting Bronchodilators Inhaler
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Homecare
7.6.2. Hospitals
7.6.3. Clinics
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Type
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
8.5.1. Reliever Inhaler
8.5.2. Long-Acting Bronchodilators Inhaler
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Homecare
8.6.2. Hospitals
8.6.3. Clinics
8.7. Market Attractiveness Analysis
9. Latin America Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Type
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
9.5.1. Reliever Inhaler
9.5.2. Long-Acting Bronchodilators Inhaler
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Homecare
9.6.2. Hospitals
9.6.3. Clinics
9.7. Market Attractiveness Analysis
10. Middle East & Africa Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Type
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
10.5.1. Reliever Inhaler
10.5.2. Long-Acting Bronchodilators Inhaler
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Homecare
10.6.2. Hospitals
10.6.3. Clinics
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Type Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Cipla Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Type
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Presspart Manufacturing Ltd
11.3.2.1. Overview
11.3.2.2. Segments and Type
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Midascare Pharmaceuticals Pvt. Ltd
11.3.3.1. Overview
11.3.3.2. Segments and Type
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Beximco Pharma Ltd.
11.3.4.1. Overview
11.3.4.2. Segments and Type
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
11.3.5.1. Overview
11.3.5.2. Segments and Type
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. 3M Pharmaceuticals Pty Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Type
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Biocare Manufacturing Sdn Bhd.
11.3.7.1. Overview
11.3.7.2. Segments and Type
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Anomatic Innovation & Design Center & Manufacturing
11.3.8.1. Overview
11.3.8.2. Segments and Type
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Aristo Pharma Ltd.
11.3.9.1. Overview
11.3.9.2. Segments and Type
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
